Earlier versions of replacement therapy to provide for missing blood proteins with human blood-bank products has been discussed previously. Current treatment involves a genetically engineered material derived from hamster cells, superior in not provoking antibodies that limit its effectiveness.
You can view these verses in a wider context by proceeding to 'To Clot, or Not to Clot' on our full-service blog "Edifying Nonsense". Click HERE!
No comments:
Post a Comment